Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bazedoxifene

Known as: 1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-, bazedoxifene/conjugated estrogens 
An indole derivative and third-generation selective estrogen receptor modulator (SERM) with potential antineoplastic activity. Upon administration… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
SummaryIn this 2-year extension of a 3-year study, bazedoxifene showed sustained efficacy in preventing new vertebral fractures… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
SummaryFindings from this 5-year phase 3 study of postmenopausal women with osteoporosis showed that bazedoxifene was associated… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Objectives: The primary objective of the Selective estrogen Menopause And Response to Therapy 3 (SMART-3) trial was to compare… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To evaluate the efficacy of the tissue-selective estrogen complex, bazedoxifene/conjugated estrogens (BZA/CE), for… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Objective: The aim of this study was to assess the safety and efficacy of bazedoxifene (BZA)/conjugated estrogens (CE) treating… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To evaluate the endometrial safety of a tissue selective estrogen complex (TSEC; pairing of a selective estrogen… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To evaluate the effects of a tissue-selective estrogen complex (TSEC) composed of bazedoxifene/conjugated estrogens… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
INTRODUCTION Bazedoxifene has been shown to significantly decrease the risk of vertebral fractures in postmenopausal women. No… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
In this 3-yr, randomized, double-blind, placebo- and active-controlled study, healthy postmenopausal women with osteoporosis (55… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
UNLABELLED Osteoporosis is an increasingly common health concern in postmenopausal women. In a 2-yr phase III study, bazedoxifene… Expand
Is this relevant?